ATE442848T1 - Isoxazolsäure-derivat zur linderung neuropathischer schmerzen - Google Patents

Isoxazolsäure-derivat zur linderung neuropathischer schmerzen

Info

Publication number
ATE442848T1
ATE442848T1 AT05815995T AT05815995T ATE442848T1 AT E442848 T1 ATE442848 T1 AT E442848T1 AT 05815995 T AT05815995 T AT 05815995T AT 05815995 T AT05815995 T AT 05815995T AT E442848 T1 ATE442848 T1 AT E442848T1
Authority
AT
Austria
Prior art keywords
neuropathic pain
acid derivative
isoxazolic
relieving neuropathic
isoxazolic acid
Prior art date
Application number
AT05815995T
Other languages
English (en)
Inventor
Mauro Napoletano
Ermanno Moriggi
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE442848T1 publication Critical patent/ATE442848T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05815995T 2004-11-16 2005-11-14 Isoxazolsäure-derivat zur linderung neuropathischer schmerzen ATE442848T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002187A ITMI20042187A1 (it) 2004-11-16 2004-11-16 Derivati isossazolici per allievare il dolore neiropatico
PCT/EP2005/055940 WO2006053860A1 (en) 2004-11-16 2005-11-14 Isoxazolic derivative to relieve neuropathic pain

Publications (1)

Publication Number Publication Date
ATE442848T1 true ATE442848T1 (de) 2009-10-15

Family

ID=35840677

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05815995T ATE442848T1 (de) 2004-11-16 2005-11-14 Isoxazolsäure-derivat zur linderung neuropathischer schmerzen

Country Status (16)

Country Link
US (1) US7834040B2 (de)
EP (1) EP1817029B1 (de)
AT (1) ATE442848T1 (de)
CA (1) CA2586664C (de)
CY (1) CY1110563T1 (de)
DE (1) DE602005016711D1 (de)
DK (1) DK1817029T3 (de)
EA (1) EA013905B1 (de)
ES (1) ES2331921T3 (de)
HR (1) HRP20090592T1 (de)
IT (1) ITMI20042187A1 (de)
PL (1) PL1817029T3 (de)
PT (1) PT1817029E (de)
RS (1) RS51020B (de)
SI (1) SI1817029T1 (de)
WO (1) WO2006053860A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317588B1 (de) * 1987-05-20 1991-08-07 ZAMBON GROUP S.p.A. Isoxazole mit nootropischer wirkung

Also Published As

Publication number Publication date
WO2006053860A1 (en) 2006-05-26
US7834040B2 (en) 2010-11-16
PT1817029E (pt) 2009-11-20
EA013905B1 (ru) 2010-08-30
ITMI20042187A1 (it) 2005-02-16
DK1817029T3 (da) 2009-12-14
RS51020B (sr) 2010-10-31
SI1817029T1 (sl) 2010-01-29
PL1817029T3 (pl) 2010-02-26
DE602005016711D1 (de) 2009-10-29
EP1817029A1 (de) 2007-08-15
ES2331921T3 (es) 2010-01-20
EP1817029B1 (de) 2009-09-16
EA200701086A1 (ru) 2007-12-28
CY1110563T1 (el) 2015-04-29
HRP20090592T1 (hr) 2009-12-31
CA2586664A1 (en) 2006-05-26
US20080108679A1 (en) 2008-05-08
CA2586664C (en) 2012-09-18

Similar Documents

Publication Publication Date Title
EA202091303A2 (ru) Композиция ингибитора jak для местного применения
MX374396B (es) Rocio de fentanilo sublingual.
WO2009066152A3 (en) Haloallylamine inhibitors of ssao/vap-1 and uses therefor
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
EA200900343A1 (ru) Устойчивые оральные фармацевтические дозированные формы, содержащие опиоидный анальгетик
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
EA200800147A1 (ru) Способ получения олмесартан медоксомила
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
MX2009004017A (es) Usos de los compuestos carboxi-amido triazol y sus sales.
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
SE0400184D0 (sv) New therapeutical use
MX362830B (es) Agente terapeutico o profilactico para enfermedades del tracto biliar.
PL2244703T3 (pl) Lekarstwo, jego wytwarzanie i zastosowanie w leczeniu bolesnych neuropatii
EA200901237A1 (ru) Применение димирацетама при лечении хронической боли
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
GB2446341A (en) Method and system for transdermal drug delivery
UA94042C2 (ru) Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса
GEP20125526B (en) Drug active in neuropathic pain
DE602005016711D1 (de) Isoxazolsäure-derivat zur linderung neuropathischer schmerzen
DE502007006951D1 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
WO2010027189A3 (ko) 호모아이소플라베논 또는 이의 염의 신규한 용도
EA200970368A1 (ru) Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1817029

Country of ref document: EP